Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin

Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2023-04, Vol.50 (4), p.e115-e116
Hauptverfasser: Hasui, Ken‐Ichi, Kawakami, Yoshio, Miyake, Tomoko, Hirai, Yoji, Nomura, Hayato, Edamura, Kohei, Araki, Motoo, Morizane, Shin
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal
Blister - chemically induced
Carcinoma, Transitional Cell
Dyskeratosis
Humans
Monoclonal antibodies
Skin Abnormalities
Skin Diseases
Toxicity
Urinary Bladder Neoplasms
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e116
container_issue 4
container_start_page e115
container_title Journal of dermatology
container_volume 50
creator Hasui, Ken‐Ichi
Kawakami, Yoshio
Miyake, Tomoko
Hirai, Yoji
Nomura, Hayato
Edamura, Kohei
Araki, Motoo
Morizane, Shin
description
doi_str_mv 10.1111/1346-8138.16646
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2793858027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2793858027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3956-27911a1995f858346575ea8ee08f24a3f7d3b02bff1c9563366eb638293b41b13</originalsourceid><addsrcrecordid>eNqFkM1PwyAcQInRuDk9ezMknrvx0VJ6NHN-ZYkXPRNYQdm6MoE6-9_L3PQqFxJ4vF94AFxiNMZpTTDNWcYx5WPMWM6OwPDv5BgMEeVFRnJUDsBZCEuESFVgdAoGlOWYEI6GYDXtomy16wKM7ssubOzh1sZ3GLqNl0oG2UDV2BC1D1C2Naz7sNJeRhdsgMY1jdva9g3Kem3bhKUb61roDNStcT52a6ngp65dtO05ODGyCfrisI_A693sZfqQzZ_vH6c382xBq4JlpKwwlriqCsMLnr5TlIWWXGvEDcklNWVNFSLKGLxIPKWMacUoJxVVOVaYjsD13rvx7qPTIYql63ybRorkTk04ImWiJntq4V0IXhux8XYtfS8wEru4YpdS7FKKn7jpxdXB26m1rv_435oJKPbA1ja6_88nnm5ne_E3C7yFMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2793858027</pqid></control><display><type>article</type><title>Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hasui, Ken‐Ichi ; Kawakami, Yoshio ; Miyake, Tomoko ; Hirai, Yoji ; Nomura, Hayato ; Edamura, Kohei ; Araki, Motoo ; Morizane, Shin</creator><creatorcontrib>Hasui, Ken‐Ichi ; Kawakami, Yoshio ; Miyake, Tomoko ; Hirai, Yoji ; Nomura, Hayato ; Edamura, Kohei ; Araki, Motoo ; Morizane, Shin</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16646</identifier><identifier>PMID: 36412280</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibodies, Monoclonal ; Blister - chemically induced ; Carcinoma, Transitional Cell ; Dyskeratosis ; Humans ; Monoclonal antibodies ; Skin Abnormalities ; Skin Diseases ; Toxicity ; Urinary Bladder Neoplasms</subject><ispartof>Journal of dermatology, 2023-04, Vol.50 (4), p.e115-e116</ispartof><rights>2022 Japanese Dermatological Association.</rights><rights>Copyright © 2023 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3956-27911a1995f858346575ea8ee08f24a3f7d3b02bff1c9563366eb638293b41b13</citedby><cites>FETCH-LOGICAL-c3956-27911a1995f858346575ea8ee08f24a3f7d3b02bff1c9563366eb638293b41b13</cites><orcidid>0000-0003-1374-065X ; 0000-0002-2644-6380 ; 0000-0001-5609-6118 ; 0000-0003-2201-6129 ; 0000-0002-8172-3029</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.16646$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.16646$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36412280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasui, Ken‐Ichi</creatorcontrib><creatorcontrib>Kawakami, Yoshio</creatorcontrib><creatorcontrib>Miyake, Tomoko</creatorcontrib><creatorcontrib>Hirai, Yoji</creatorcontrib><creatorcontrib>Nomura, Hayato</creatorcontrib><creatorcontrib>Edamura, Kohei</creatorcontrib><creatorcontrib>Araki, Motoo</creatorcontrib><creatorcontrib>Morizane, Shin</creatorcontrib><title>Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><subject>Antibodies, Monoclonal</subject><subject>Blister - chemically induced</subject><subject>Carcinoma, Transitional Cell</subject><subject>Dyskeratosis</subject><subject>Humans</subject><subject>Monoclonal antibodies</subject><subject>Skin Abnormalities</subject><subject>Skin Diseases</subject><subject>Toxicity</subject><subject>Urinary Bladder Neoplasms</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1PwyAcQInRuDk9ezMknrvx0VJ6NHN-ZYkXPRNYQdm6MoE6-9_L3PQqFxJ4vF94AFxiNMZpTTDNWcYx5WPMWM6OwPDv5BgMEeVFRnJUDsBZCEuESFVgdAoGlOWYEI6GYDXtomy16wKM7ssubOzh1sZ3GLqNl0oG2UDV2BC1D1C2Naz7sNJeRhdsgMY1jdva9g3Kem3bhKUb61roDNStcT52a6ngp65dtO05ODGyCfrisI_A693sZfqQzZ_vH6c382xBq4JlpKwwlriqCsMLnr5TlIWWXGvEDcklNWVNFSLKGLxIPKWMacUoJxVVOVaYjsD13rvx7qPTIYql63ybRorkTk04ImWiJntq4V0IXhux8XYtfS8wEru4YpdS7FKKn7jpxdXB26m1rv_435oJKPbA1ja6_88nnm5ne_E3C7yFMw</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Hasui, Ken‐Ichi</creator><creator>Kawakami, Yoshio</creator><creator>Miyake, Tomoko</creator><creator>Hirai, Yoji</creator><creator>Nomura, Hayato</creator><creator>Edamura, Kohei</creator><creator>Araki, Motoo</creator><creator>Morizane, Shin</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0003-1374-065X</orcidid><orcidid>https://orcid.org/0000-0002-2644-6380</orcidid><orcidid>https://orcid.org/0000-0001-5609-6118</orcidid><orcidid>https://orcid.org/0000-0003-2201-6129</orcidid><orcidid>https://orcid.org/0000-0002-8172-3029</orcidid></search><sort><creationdate>202304</creationdate><title>Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin</title><author>Hasui, Ken‐Ichi ; Kawakami, Yoshio ; Miyake, Tomoko ; Hirai, Yoji ; Nomura, Hayato ; Edamura, Kohei ; Araki, Motoo ; Morizane, Shin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3956-27911a1995f858346575ea8ee08f24a3f7d3b02bff1c9563366eb638293b41b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies, Monoclonal</topic><topic>Blister - chemically induced</topic><topic>Carcinoma, Transitional Cell</topic><topic>Dyskeratosis</topic><topic>Humans</topic><topic>Monoclonal antibodies</topic><topic>Skin Abnormalities</topic><topic>Skin Diseases</topic><topic>Toxicity</topic><topic>Urinary Bladder Neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasui, Ken‐Ichi</creatorcontrib><creatorcontrib>Kawakami, Yoshio</creatorcontrib><creatorcontrib>Miyake, Tomoko</creatorcontrib><creatorcontrib>Hirai, Yoji</creatorcontrib><creatorcontrib>Nomura, Hayato</creatorcontrib><creatorcontrib>Edamura, Kohei</creatorcontrib><creatorcontrib>Araki, Motoo</creatorcontrib><creatorcontrib>Morizane, Shin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasui, Ken‐Ichi</au><au>Kawakami, Yoshio</au><au>Miyake, Tomoko</au><au>Hirai, Yoji</au><au>Nomura, Hayato</au><au>Edamura, Kohei</au><au>Araki, Motoo</au><au>Morizane, Shin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2023-04</date><risdate>2023</risdate><volume>50</volume><issue>4</issue><spage>e115</spage><epage>e116</epage><pages>e115-e116</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36412280</pmid><doi>10.1111/1346-8138.16646</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-1374-065X</orcidid><orcidid>https://orcid.org/0000-0002-2644-6380</orcidid><orcidid>https://orcid.org/0000-0001-5609-6118</orcidid><orcidid>https://orcid.org/0000-0003-2201-6129</orcidid><orcidid>https://orcid.org/0000-0002-8172-3029</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2023-04, Vol.50 (4), p.e115-e116
issn 0385-2407
1346-8138
language eng
recordid cdi_proquest_journals_2793858027
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antibodies, Monoclonal
Blister - chemically induced
Carcinoma, Transitional Cell
Dyskeratosis
Humans
Monoclonal antibodies
Skin Abnormalities
Skin Diseases
Toxicity
Urinary Bladder Neoplasms
title Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A21%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutaneous%20toxicity%20with%20suprabasal%20blisters%20and%20dyskeratosis%20following%20administration%20of%20enfortumab%20vedotin&rft.jtitle=Journal%20of%20dermatology&rft.au=Hasui,%20Ken%E2%80%90Ichi&rft.date=2023-04&rft.volume=50&rft.issue=4&rft.spage=e115&rft.epage=e116&rft.pages=e115-e116&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16646&rft_dat=%3Cproquest_cross%3E2793858027%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2793858027&rft_id=info:pmid/36412280&rfr_iscdi=true